Suppr超能文献

公众对 COVID-19 疫苗信息的易读性。

Readability of COVID-19 vaccine information for the general public.

机构信息

Mayo Vaccine Research Group, Mayo Clinic, Rochester, MN, USA.

Mayo Vaccine Research Group, Mayo Clinic, Rochester, MN, USA.

出版信息

Vaccine. 2022 May 31;40(25):3466-3469. doi: 10.1016/j.vaccine.2022.04.096. Epub 2022 May 3.

Abstract

BACKGROUND

More than 130 million individuals in the United States have now received at least one dose of a COVID-19 vaccine. Currently, all adults in the Unites States now have access to one of three COVID-19 vaccines. As part of the vaccination procedure, Emergency Use Authorization (EUA) fact sheets, which contain information regarding the vaccine, are provided. The purpose of this study was to analyze the ease of reading (i.e., readability) of the EUA-approved fact sheets for the vaccines currently available in the United States, the V-Safe adverse event survey script, and the Centers for Disease Control and Prevention (CDC) website information on COVID-19 vaccines designed for the general public in the United States.

METHODS

We acquired the Pfizer, Moderna, and Janssen EUA fact sheets, as well as the V-Safe survey script and the CDC website information regarding COVID-19 vaccines. These documents were analyzed for their complexity regarding the following readability factors: average length of paragraphs, sentences, and words; font size and style; use of passive voice; the Gunning-Fog index; the Flesch Reading Ease index; and the Flesch-Kincaid Grade Level index.

RESULTS

Only the V-Safe adverse-event survey script met readability standards for adequate comprehension. The mean readability scores of the EUA fact sheets and the CDC website were as follows: Flesch Reading Ease score (44.35 avg); Flesch-Kincaid Grade Level (10.48 avg); and Gunning-Fog index (11.8 avg).These scores indicate that at least a 10th-grade level education would be required to understand these reading materials.

CONCLUSION

The average person in the United States would have difficulty understanding the information provided in the EUA fact sheets and CDC COVID-19 vaccine website documents; however, the V-Safe survey was written at an adequate reading level. To ensure that the general public fully understands information regarding COVID-19 vaccines, greater care and effort should be given to the development of simplified information material.

摘要

背景

目前,美国已有超过 1.3 亿人至少接种了一剂 COVID-19 疫苗。目前,美国所有成年人都可以使用三种 COVID-19 疫苗中的一种。作为疫苗接种程序的一部分,会提供包含疫苗相关信息的紧急使用授权(EUA)情况说明书。本研究旨在分析美国目前可用的疫苗(辉瑞、莫德纳和强生)、V-Safe 不良事件调查脚本以及美国疾病控制与预防中心(CDC)面向公众的 COVID-19 疫苗网站信息的易读性(即可读性)。

方法

我们获取了辉瑞、莫德纳和强生的 EUA 情况说明书,以及 V-Safe 调查脚本和 CDC 网站上的 COVID-19 疫苗信息。我们分析了这些文件的复杂性,涉及以下可读性因素:段落、句子和单词的平均长度;字体大小和样式;被动语态的使用;Gunning-Fog 指数;Flesch 阅读舒适度指数;以及 Flesch-Kincaid 年级水平指数。

结果

只有 V-Safe 不良事件调查脚本符合充分理解的可读性标准。EUA 情况说明书和 CDC 网站的平均可读性评分如下:Flesch 阅读舒适度评分(44.35 分);Flesch-Kincaid 年级水平(10.48 分);以及 Gunning-Fog 指数(11.8 分)。这些分数表明,至少需要 10 年级的教育水平才能理解这些阅读材料。

结论

美国的普通民众理解 EUA 情况说明书和 CDC COVID-19 疫苗网站文件中提供的信息会有困难;然而,V-Safe 调查的写作水平是足够的。为了确保公众充分了解 COVID-19 疫苗的信息,应该更加关注简化信息材料的开发。

相似文献

1
Readability of COVID-19 vaccine information for the general public.公众对 COVID-19 疫苗信息的易读性。
Vaccine. 2022 May 31;40(25):3466-3469. doi: 10.1016/j.vaccine.2022.04.096. Epub 2022 May 3.
7
Anxiety and COVID-19: A study of online content readability.焦虑与 COVID-19:在线内容可读性研究。
J Prev Interv Community. 2021 Apr-Jun;49(2):193-201. doi: 10.1080/10852352.2021.1908874. Epub 2021 Apr 19.

本文引用的文献

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验